| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |